Johnson & Johnson Simponi Simponi Aria — Percent Change (as a percent) increased by 27.8% to 109.5% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 304.7%, from -53.5% to 109.5%. This is a positive signal — higher values indicate stronger performance for this metric.
Positive growth indicates expanding market share or increased patient utilization, whereas negative growth suggests potential market saturation or competitive pressure.
This metric measures the period-over-period percentage growth or decline in net sales for the Simponi and Simponi Aria p...
Comparable to year-over-year or quarter-over-quarter revenue growth rates for specific pharmaceutical products across the industry.
jnj_segment_simponi_simponi_aria_percent_change_as_a_percent| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 19.2% | 21.4% | -9.7% | 6.4% | -8.9% | -14.1% | -17.5% | 48.3% | 9.2% | 6.2% | -53.5% | 56.1% | 85.7% | 109.5% |
| QoQ Change | — | +11.5% | -145.3% | +166.0% | -239.1% | -58.4% | -24.1% | +376.0% | -81.0% | -32.6% | -962.9% | +204.9% | +52.8% | +27.8% |
| YoY Change | — | — | — | -66.7% | -141.6% | -45.4% | -373.4% | +642.7% | — | +135.4% | -210.8% | +509.8% | >999% | +304.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.